GYRE Gyre Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 7, 2026
$7,11
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$5,4452 haftanın en düşüğü
$9,4252 haftanın en yükseği
Piyasa Değeri (MRQ)
$754M
P/E (TTM)
-35.5
Hisse Başına Kâr (TTM)
$-0.20
Gelir (TTM)
$119M
rozetleriniz
52 Haftlık Aralık
$5–$9
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$19
P/E
-35.5
ROE
-28.3%
Net Kâr Marjı
-23.7%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
GYRE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$7.11
Piyasa Değeri (MRQ)
$754M
P/E (TTM)
-35.5
Hisse Başına Kâr (TTM)
$-0.20
Gelir (TTM)
$119M
ROE (TTM)
-28.3%
52 Haftlık Aralık
$5–$9
GYRE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 31 Ekim 2023 | 1-for-15 | Ters |
| 13 Şubat 2017 | 1-for-15 | Ters |
| 21 Ağustos 2015 | 1-for-7 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$117M2017-12-31 → 2025-12-31
Hisse Başına Kâr$0.022021-12-31 → 2025-12-31
Serbest Nakit Akışı$-180.0K2016-12-31 → 2025-12-31
Net kar marjı-23.7%2020-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | GYRE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -35.55Y ort. ≈167.4 | ≈167.4 | · | · | |
| F/S (TTM) | 6.35Y ort. ≈8.9 | ≈8.9 | 8.0 | Düşük değerli | |
| F/D (MRQ) | 7.05Y ort. ≈-28.9 | ≈-28.9 | 3.2 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -47.95Y ort. ≈-1214.5 | ≈-1214.5 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -52.05Y ort. ≈104.6 | ≈104.6 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 7.35Y ort. ≈10.1 | ≈10.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | GYRE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -14.0%5Y ort. ≈-11.4% | ≈-11.4% | -1043.3% | En üst düzey | |
| FAVÖK Marjı (TTM) | -11.1%5Y ort. ≈-9.9% | ≈-9.9% | -1043.3% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | -13.5%5Y ort. ≈-11.2% | ≈-11.2% | · | · | |
| Net Kâr Marjı (TTM) | -23.7%5Y ort. ≈-16.7% | ≈-16.7% | -989.0% | En üst düzey | |
| ROA (TTM) | -16.1%5Y ort. ≈-20.7% | ≈-20.7% | -33.0% | En üst düzey | |
| ROE (TTM) | -28.3%5Y ort. ≈65.0% | ≈65.0% | -39.4% | En üst düzey | |
| ROIC | 7.4%5Y ort. ≈135.1% | ≈135.1% | -32.0% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | GYRE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 4.35Y ort. ≈3.4 | ≈3.4 | 11.3 | Düşük likidite | |
| Cari Oran (MRQ) | 3.05Y ort. ≈2.5 | ≈2.5 | 6.6 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | GYRE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 10.2%5Y ort. ≈248.7% | ≈248.7% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 4.5%5Y ort. ≈74.5% | ≈74.5% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 41.0% | · | · | · | |
| EPS YoY (EPS YB) | -60.0% | · | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | -44.8% | · | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | -12.6% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 31.8% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | GYRE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.85Y ort. ≈0.9 | ≈0.9 | 0.0 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 4.6 | · | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$186.5K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Yıllıklaştırılmış Ödeme≈$3.60
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Oca 13, 2023 | $3,60 | USD | ≈642.3% |
| Eyl 21, 2022 | $21,45 | USD | ≈286.0% |
| Ağu 20, 2015 | $896,18 | USD | ≈59.3% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
13.3%
Sonraki Rapor
Kas 05, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 18, 2026 | $-0.12 | $-0.09 | -30.7% |
| 31 Mart 2026 | May 8, 2026 | $-0.10 | $-0.07 | -33.7% |
| 31 Aralık 2025 | $0.05 | $0.06 | -13.5% | |
| 30 Eylül 2025 | $0.08 | $0.03 | 194.1% | |
| 30 Haziran 2025 | $0.02 | $0.03 | -34.6% | |
| 31 Mart 2025 | $0.03 | $0.03 | -2.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | · | · | $275.0K | |
| Cost of Revenue | $5M | $4M | $5M | $5M | · | · | · | · | · | · | · | · | |
| Gross Profit | · | $102M | $109M | $97M | · | · | · | · | · | · | · | · | |
| R&D Expense | $14M | $12M | $14M | · | $69M | $53M | $44M | $21M | $13M | $12M | $6M | $5M | |
| SG&A Expense | $21M | $16M | $15M | $17M | $19M | $16M | $13M | $12M | $10M | $9M | $10M | $4M | |
| Operating Expenses | $105M | $90M | $176M | $88M | $95M | $78M | $57M | $34M | $23M | $21M | $16M | $9M | |
| Operating Income | $11M | $16M | $-67M | $9M | $-88M | $-57M | $-57M | $-34M | $-22M | $-20M | $-14M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $1M | $23.0K | |
| Other Non-op | $-2M | $-2M | $-2M | · | $-78.0K | $-91.0K | $-39.0K | $2M | $-1.0K | $86.0K | $131.0K | $575.0K | |
| Pretax Income | $14M | $23M | $-77M | $9M | $-88M | · | · | · | · | · | · | $-29M | |
| Income Tax | $5M | $5M | $9M | $5M | · | · | · | · | · | · | · | $3M | |
| Net Income | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| EPS (Basic) | $0.06 | $0.14 | $-1.41 | $0.04 | $-2.87 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | · | · | · | · | · | · | · | |
| Shares (Basic) | 89,344,622 | 85,094,948 | 65,831,675 | 63,588,119 | 30,640,977 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 103,180,037 | 102,293,526 | 65,831,675 | 75,686,406 | 30,640,977 | · | · | · | · | · | · | · | |
| EBITDA | $14M | $18M | $-66M | $-8M | · | $-57M | $-57M | · | $-22M | $-20M | $-13M | $-29M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $12M | $34M | $25M | $44M | $30M | $15M | $31M | $14M | $10M | $29M | $2M | |
| Short-term Investments | $15M | $15M | · | · | $3M | $49M | $61M | $89M | $18M | $7M | $3M | $51M | |
| Receivables | $31M | $20M | $15M | · | $2M | $3M | $15M | · | · | · | · | $141.0K | |
| Inventory | $10M | $6M | $4M | $6M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $10M | $3M | · | $2M | $3M | $7M | $4M | $4M | $1M | $958.0K | $2M | $103.0K | |
| Other Current Assets | $1M | $1M | $1M | $843.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $149M | $65M | $57M | $50M | $51M | $90M | $96M | $124M | $39M | $38M | $69M | $2M | |
| PP&E (Net) | $28M | $24M | $23M | $18M | $970.0K | $433.0K | $304.0K | $386.0K | $276.0K | $444.0K | $698.0K | $911.0K | |
| PP&E (Gross) | $39M | $29M | $28M | $22M | · | · | · | $671.0K | $2M | $2M | $6M | $8M | |
| Accum. Depreciation | $11M | $6M | $4M | $4M | · | · | $400.0K | $300.0K | $2M | $2M | $6M | $7M | |
| Intangibles | $5M | $273.0K | $273.0K | $297.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $3M | $995.0K | $3M | $472.0K | $528.0K | $257.0K | $543.0K | $128.0K | · | · | $12.0K | |
| Total Assets | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Accounts Payable | $1M | $108.0K | $355.0K | $122.0K | $6M | $6M | $4M | $1M | $747.0K | $837.0K | $939.0K | $249.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Current Liabilities | $24M | $20M | $20M | $12M | $14M | $18M | $29M | $5M | $9M | $22M | $38M | $2M | |
| Capital Leases | $2M | $885.0K | $199.0K | $121.0K | $408.0K | $981.0K | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $7.0K | $49.0K | $55.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $31M | $27M | $38M | $13M | $15M | $19M | $30M | $5M | $9M | $22M | $38M | $3M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $91.0K | $86.0K | $77.0K | $64.0K | $31.0K | $22.0K | $12.0K | $12.0K | $6.0K | $1.0K | $1.0K | $34.0K | |
| Paid-in Capital | $173M | $136M | $68M | $33M | $444M | $391M | $327M | $323M | $204M | $164M | $162M | $7M | |
| Retained Earnings | $-113M | $-73M | $-86M | $7M | $-403M | $-315M | $-259M | $-203M | $-173M | $-148M | $-131M | $-116M | |
| AOCI | $-908.0K | $-3M | $-2M | $-392.0K | · | $5.0K | $34.0K | $-4.0K | · | $-1.0K | $1.0K | $4.0K | |
| Stockholders' Equity | $62M | $63M | $-16M | $43M | $41M | $76M | $68M | $120M | $31M | $16M | $31M | $-109M | |
| Liabilities + Equity | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Shares Outstanding | 91,314,007 | 86,307,544 | 76,595,616 | 63,588,119 | 31,409,707 | 22,097,820 | 12,040,835 | 11,954,528 | 6,081,230 | 801,756 | 762,005 | 370,944 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $1M | $290.0K | $138.0K | $146.0K | $149.0K | $173.0K | $389.0K | $470.0K | $680.0K | |
| Stock-based Comp | $7M | $831.0K | $7M | $13M | $3M | $4M | $3M | $3M | $863.0K | $635.0K | $326.0K | $244.0K | |
| Deferred Tax | $-1M | $-1M | $-834.0K | $-890.0K | · | · | · | · | · | · | · | $72.0K | |
| Amort. of Intangibles | $576.0K | $38.0K | $100.0K | $200.0K | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-17M | $-23M | $104M | $-26M | · | $-3M | $8M | · | $585.0K | $-3M | $-5M | $-6M | |
| Operating Cash Flow | $1M | $-4M | $26M | $11M | $-84M | $-55M | $-44M | $-29M | $-20M | $-18M | $-19M | $-6M | |
| CapEx | $1M | $2M | $9M | $5M | $839.0K | · | $64.0K | $376.0K | $23.0K | $468.0K | $272.0K | $4.0K | |
| Investing Cash Flow | $-474.0K | $-20M | $-20M | $-14M | $48M | $10M | $27M | $-71M | $-11M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $-1M | |
| Stock Issued | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | · | $296.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $82.0K | · | |
| Net Stock Activity | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | $-82.0K | $296.0K | |
| Dividends Paid | · | · | · | $45M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $2M | $-45M | $50M | $60M | $327.0K | $111M | $21M | · | · | · | |
| Net Change in Cash | $25M | $-22M | $8M | $-5M | $14M | $15M | $-16M | $11M | $-10M | $-19M | $28M | $-1M | |
| Taxes Paid | $6M | $9M | $6M | $6M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-180.0K | $-6M | $17M | · | · | · | $-44M | · | $-20M | $-19M | $-19M | $-34M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-35M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 96.3% | 95.9% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | 9.8% | 15.3% | -59.3% | · | · | -273.9% | · | · | · | · | · | -10805.1% | |
| Net Margin | 8.5% | 16.9% | -75.3% | · | · | -268.5% | · | · | · | · | · | -11862.9% | |
| Pretax Margin | 12.4% | 21.9% | -67.8% | · | · | · | · | · | · | · | · | -10596.0% | |
| EBITDA Margin | 12.0% | 16.8% | -58.3% | · | · | -273.2% | · | · | · | · | · | -10677.5% | |
| ROA | 6.8% | 14.8% | -84.9% | -19.6% | · | -58.2% | -49.4% | · | -55.6% | -31.5% | -40.7% | -25.3% | |
| ROE | 11.7% | 75.4% | 387.3% | -214.5% | · | -66.1% | -73.8% | · | -92.0% | -71.4% | 37.9% | -1073.6% | |
| ROIC | 7.4% | 19.7% | 471.8% | 41.4% | · | · | · | · | · | · | · | -30.5% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.6 | 3.3 | 2.9 | 1.7 | · | 5.0 | 3.3 | · | 4.5 | 1.7 | 1.8 | 37.1 | |
| Quick Ratio | 4.6 | 2.4 | 1.7 | 1.3 | · | 4.6 | 3.2 | · | 3.7 | 0.8 | 0.9 | 36.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -9.3 | -1291.9 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.9 | 1.1 | · | · | 0.2 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | 0.7 | 0.9 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | 6.1 | · | · | · | 2.3 | · | · | · | · | · | 1.3 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.16 | $0.73 | $-0.21 | $-0.57 | · | $3.44 | $5.68 | · | $5.06 | $20.04 | $2.75 | $3.23 | |
| Revenue / Share | $1.13 | $1.03 | $1.72 | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.01 | $-0.04 | $0.39 | $-1.05 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.41 | $0.14 | $0.44 | $0.57 | · | $1.37 | $1.28 | · | $2.38 | $12.80 | $2.55 | $1.67 | |
| Dividend / Share | · | · | · | $0.24 | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | · | · | · | $1.43 | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -6.8% | 10.9% | 1294.0% | -65.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 143.4% | 75.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 41.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -60.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -12.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -44.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 31.8% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | $248.0K | $248.0K | $275.0K | |
| Net Income TTM | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| Market Cap | $645M | $1.04B | $1.97B | $300M | · | $2.09B | $1.23B | · | $1.24B | $117M | $8.05B | $139.98B | |
| P/E | 353.0 | 242.0 | -18.2 | 265.0 | -4.8 | -64.8 | -70.0 | -81.1 | -140.1 | -100.2 | -482.4 | -2837.2 | |
| P/S | 5.5 | 9.9 | 17.3 | 2.9 | · | 99.8 | · | · | 1222.2 | 472.8 | 32458.2 | 509025.8 | |
| P/B | 6.1 | 16.5 | -124.3 | -13.8 | · | 27.5 | 18.0 | · | 40.4 | 7.3 | 256.2 | 1283.2 | |
| P / Tangible Book | 6.4 | 16.6 | · | 7.1 | 10.4 | 27.5 | · | · | · | · | · | · | |
| P / Cash Flow | 638.3 | -286.8 | 76.0 | -9.1 | · | -38.0 | -28.2 | · | -62.4 | -6.3 | -421.1 | -4059.5 | |
| P / FCF | -3581.5 | -175.3 | 113.3 | · | · | · | -28.2 | · | -62.3 | -6.2 | -415.1 | -4059.0 | |
| Dividend Yield | · | · | · | 15.0% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.28% | 0.41% | -5.5% | 0.38% | -21.0% | -1.5% | -1.4% | -1.2% | -0.71% | -1.0% | -0.21% | -0.04% | |
| Payout Ratio | · | · | · | -546.4% | · | · | · | · | · | · | · | · | |
| Annual Payout | · | · | · | $45M | · | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $23M | $37M | $31M | $30M | $22M | $28M | $25M | $25M | $27M | $27M | $32M | $29M | $25M | · | · | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $1M | $894.0K | $1M | $958.0K | $770.0K | $979.0K | $1M | $1M | $1M | $1M | · | · | |
| Gross Profit | · | · | · | $29M | $26M | $21M | · | $25M | $24M | $26M | $26M | $31M | $28M | $24M | · | · | |
| R&D Expense | · | $7M | $5M | $2M | $8M | $3M | $4M | $3M | $3M | $2M | $5M | $3M | $4M | $3M | · | $803.0K | |
| SG&A Expense | $8M | $7M | $7M | $4M | $7M | $5M | $5M | $4M | $3M | $3M | $10M | $1M | $2M | $2M | $4M | $4M | |
| Operating Expenses | $43M | $32M | $41M | $22M | $32M | $20M | $30M | $20M | $21M | $18M | $118M | $18M | $23M | $17M | $119M | $5M | |
| Operating Income | $-14M | $-9M | $118.0K | $7M | $-2M | $2M | $665.0K | $4M | $3M | $8M | $-92M | $13M | $5M | $7M | $-22M | $-5M | |
| Other Non-op | $-943.0K | $29.0K | $-2M | $727.0K | $-488.0K | $107.0K | $-2M | $-75.0K | $-72.0K | $122.0K | $-237.0K | $-1M | $629.0K | · | · | $-1.0K | |
| Pretax Income | $-14M | $-9M | $-66.0K | $8M | $-2M | $5M | $772.0K | $4M | $6M | $12M | $-100M | $11M | $6M | $6M | $-23M | $-5M | |
| Income Tax | $-164.0K | $621.0K | $1M | $2M | $662.0K | $901.0K | $203.0K | $1M | $1M | $3M | $699.0K | $4M | $2M | $2M | $5M | $0 | |
| Net Income | $-14M | $-19M | $-1M | $6M | $-2M | $5M | $569.0K | $3M | $5M | $10M | $-101M | $8M | $4M | $4M | $-28M | $-5M | |
| EPS (Basic) | $-0.12 | $-0.10 | $-0.01 | $0.04 | $-0.02 | $0.03 | $0.00 | $0.01 | $0.04 | $0.09 | $-1.54 | $0.06 | $0.03 | $0.04 | $-0.98 | $-0.16 | |
| EPS (Diluted) | $-0.12 | $-0.10 | $-0.01 | $0.03 | $-0.03 | $0.00 | $0.00 | $0.01 | $0.01 | $0.03 | $-1.51 | $0.05 | $0.02 | $0.03 | $-0.99 | $-0.16 | |
| Shares (Basic) | 100,637,599 | 91,317,142 | · | 90,850,040 | 89,119,344 | 86,420,530 | · | 85,643,646 | 85,502,403 | 83,265,879 | · | 63,588,119 | 63,588,119 | 63,588,119 | · | 31,484,542 | |
| Shares (Diluted) | 100,637,599 | 91,344,584 | · | 103,971,546 | 89,203,138 | 101,970,672 | · | 102,640,373 | 102,205,888 | 102,594,197 | · | 78,904,324 | 78,904,324 | 78,921,366 | · | 31,484,542 | |
| EBITDA | · | $-9M | · | $7M | $2M | $3M | · | $4M | $3M | $8M | · | $-2M | $-3M | $181.0K | · | $-5M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $38M | $37M | $40M | $36M | $15M | $12M | $16M | $16M | $30M | $34M | $2M | $7M | $8M | $25M | $23M | |
| Short-term Investments | $14M | $12M | $15M | $20M | $18M | $15M | $15M | $9M | $9M | $8M | · | · | · | · | · | · | |
| Receivables | $28M | $23M | $31M | $26M | $25M | $20M | $20M | · | · | · | $15M | · | · | · | · | · | |
| Inventory | $11M | $11M | · | · | $9M | $8M | · | $6M | $6M | $5M | $4M | · | · | · | $6M | · | |
| Prepaid Expense | $8M | $4M | · | $3M | $3M | $8M | · | · | · | · | · | · | $697.0K | $915.0K | · | $2M | |
| Other Current Assets | · | · | $1M | · | · | · | $1M | $2M | $2M | $2M | $1M | · | · | · | $843.0K | · | |
| Current Assets | $122M | $92M | $102M | $99M | $91M | $68M | $65M | $55M | $54M | $63M | $57M | $5M | $8M | $14M | $50M | $30M | |
| PP&E (Net) | $27M | $24M | $24M | $24M | $23M | $24M | $24M | $24M | $24M | $24M | $23M | · | · | $1.0K | $18M | $124.0K | |
| PP&E (Gross) | $40M | $32M | $31M | $31M | $30M | $30M | $29M | $30M | $28M | $28M | $28M | · | · | · | $22M | · | |
| Accum. Depreciation | $13M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | · | · | · | $4M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $273.0K | $184.0K | $186.0K | $196.0K | $205.0K | · | · | · | $297.0K | · | |
| Other Non-current Assets | $7M | $5M | $2M | $5M | $5M | $6M | $3M | $3M | $1M | $802.0K | $995.0K | $168.0K | $168.0K | $168.0K | $3M | $168.0K | |
| Total Assets | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Accounts Payable | $1M | $265.0K | $124.0K | $556.0K | $71.0K | $122.0K | $108.0K | $303.0K | $271.0K | $330.0K | $355.0K | $158.0K | $5.0K | $16.0K | $122.0K | $41.0K | |
| Current Liabilities | $29M | $20M | $18M | $16M | $17M | $19M | $20M | $15M | $16M | $19M | $20M | $2M | $3M | $7M | $12M | $2M | |
| Capital Leases | $2M | $72.0K | $303.0K | $539.0K | $771.0K | $780.0K | $885.0K | $1M | $1M | $175.0K | $199.0K | · | · | · | $121.0K | · | |
| Other Non-current Liabilities | $70.0K | $1M | $1M | $1M | $1M | $1M | $7.0K | $2.0K | $47.0K | $48.0K | $49.0K | · | · | · | $55.0K | · | |
| Total Liabilities | $34M | $25M | $24M | $22M | $23M | $25M | $27M | $27M | $28M | $33M | $38M | $6M | $7M | $11M | $13M | $2M | |
| Common Stock | $106.0K | $91.0K | $91.0K | $91.0K | $91.0K | $87.0K | $86.0K | $85.0K | $85.0K | $85.0K | $77.0K | $37.0K | $37.0K | $37.0K | $64.0K | $31.0K | |
| Paid-in Capital | $241M | $175M | $172M | $167M | $161M | $138M | $136M | $134M | $134M | $133M | $68M | $385M | $385M | $385M | $33M | $400M | |
| Retained Earnings | $-138M | $-78M | $-68M | $-67M | $-70M | $-71M | $-73M | $-73M | $-74M | $-78M | $-86M | $-415M | $-413M | $-411M | $7M | $-370M | |
| AOCI | $1M | $586.0K | $-779.0K | $-2M | $-2M | $-2M | $-3M | $-946.0K | $-2M | $-2M | $-2M | · | · | · | $-392.0K | · | |
| Stockholders' Equity | $108M | $101M | $106M | $102M | $92M | $68M | $63M | $63M | $60M | $57M | $-16M | $4M | $-28M | $-26M | $43M | $29M | |
| Liabilities + Equity | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Shares Outstanding | 106,033,763 | 91,337,121 | 91,314,007 | 90,890,381 | 90,822,828 | 87,636,209 | 86,307,544 | 85,769,526 | 85,537,774 | 85,423,246 | 76,595,616 | 37,978,142 | 37,974,892 | 37,759,825 | 63,588,119 | 31,490,053 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $672.0K | $656.0K | $649.0K | $641.0K | $535.0K | $461.0K | $445.0K | $228.0K | $415.0K | $298.0K | $772.0K | $581.0K | $276.0K | $867.0K | $40.0K | |
| Stock-based Comp | $2M | $3M | $5M | $1M | $906.0K | $507.0K | $567.0K | $237.0K | $16.0K | $11.0K | $7M | $98.0K | $89.0K | $210.0K | $12M | $224.0K | |
| Amort. of Intangibles | $179.0K | $175.0K | $172.0K | $170.0K | $167.0K | $67.0K | $-80.5K | $10.0K | $8.5K | $100.0K | $-7.0K | $14.0K | $48.0K | $45.0K | · | · | |
| Other Non-cash | · | $10M | · | · | · | $-5M | · | · | · | $-7M | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-17M | $3M | $-6M | $5M | $2M | $-129.0K | $-3M | $2M | $-5M | $3M | $3M | $31M | $21M | $10M | $42M | $-7M | |
| CapEx | $262.0K | $178.0K | $144.0K | $668.0K | $256.0K | $122.0K | $-65.0K | $693.0K | $1M | $231.0K | $2M | $2M | $2M | $2M | · | · | |
| Investing Cash Flow | $10M | $-3M | $2M | $-1M | $-3M | $2M | $-2M | $-2M | $-8M | $-7M | $1M | $-26M | $-16M | $-8M | $-69M | $0 | |
| Stock Issued | · | · | · | · | $22M | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | · | $2M | $4M | $8M | · | · | |
| Financing Cash Flow | $-8.0K | $21.0K | $318.0K | $365.0K | $22M | $1M | $964.0K | $324.0K | $156.0K | $658.0K | $15M | $-1M | $-4M | $-8M | · | $-45M | |
| Net Change in Cash | $-6M | $431.0K | $-3M | $4M | $21M | $3M | $-4M | $-231.0K | $-14M | $-4M | $7M | $16M | $12M | $3M | $16M | $-52M | |
| Taxes Paid | · | $1M | $1M | $687.0K | $447.0K | $3M | $761.0K | $537.0K | $6M | $1M | $961.0K | $1M | $4M | $463.0K | · | · | |
| Free Cash Flow | · | $3M | · | · | · | $-251.0K | · | · | · | $3M | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 94.7% | 95.7% | 96.0% | · | 96.2% | 97.0% | 96.4% | · | · | · | · | · | · | |
| Operating Margin | · | -41.5% | · | 22.7% | 8.1% | 10.3% | · | 16.6% | 12.9% | 29.7% | · | · | · | · | · | · | |
| Net Margin | · | -43.8% | · | 19.4% | 5.9% | 16.9% | · | 11.2% | 18.0% | 36.6% | · | · | · | · | · | · | |
| Pretax Margin | · | -41.0% | · | 25.0% | 8.4% | 21.0% | · | 15.4% | 23.9% | 45.9% | · | · | · | · | · | · | |
| EBITDA Margin | · | -38.6% | · | 22.7% | 8.1% | 12.7% | · | 16.6% | 12.9% | 31.2% | · | · | · | · | · | · | |
| ROA | · | -6.8% | · | 4.2% | 1.1% | 3.0% | · | 4.2% | 6.8% | 14.1% | · | -7.7% | -5.2% | 0.88% | · | -8.9% | |
| ROE | · | -11.6% | · | 7.2% | 2.1% | 6.0% | · | 8.6% | 28.3% | 64.8% | · | -9.6% | -9.7% | 46.0% | · | -10.8% | |
| ROIC | · | -9.8% | · | 5.3% | 1.7% | 2.7% | · | 4.9% | 4.1% | 11.3% | · | -46.2% | 9.0% | -0.65% | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.6 | · | 6.2 | 5.4 | 3.6 | · | 3.7 | 3.4 | 3.2 | · | 2.9 | 2.7 | 2.0 | · | 18.4 | |
| Quick Ratio | · | 3.7 | · | 5.4 | 4.7 | 2.6 | · | 1.7 | 1.6 | 1.9 | · | 1.2 | 2.5 | 1.2 | · | 14.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.4 | · | · | · | · | · | · | |
| Inventory Turnover | · | 0.1 | · | · | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.4 | · | · | · | · | · | · | |
| Receivables Turnover | · | 1.0 | · | 2.3 | 2.0 | 2.1 | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.11 | · | $1.12 | $1.01 | $0.78 | · | $0.74 | $0.71 | $0.66 | · | $0.09 | $-0.75 | $-0.69 | · | $0.93 | |
| Revenue / Share | · | $0.25 | · | $0.29 | $0.26 | $0.22 | · | $0.25 | $0.24 | $0.26 | · | · | · | · | · | · | |
| Cash Flow / Share | · | $0.03 | · | · | · | $-0.00 | · | · | · | $0.03 | · | · | · | $-0.16 | · | · | |
| Cash / Share | · | $0.41 | · | $0.44 | $0.40 | $0.17 | · | $0.18 | $0.19 | $0.35 | · | $0.06 | $0.18 | $0.21 | · | $0.73 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.24 | · | $1.43 | |
| EPS (TTM) | $-0.22 | $-0.11 | · | $0.00 | $-0.02 | $0.02 | · | $-1.46 | $-1.42 | $-1.41 | · | $-0.89 | $-1.10 | $0.52 | · | $0.38 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $120M | · | $110M | $105M | $101M | · | $105M | $112M | $116M | · | · | · | · | · | · | |
| Net Income TTM | $-29M | $-16M | · | $9M | $6M | $13M | · | $-84M | $-79M | $-80M | · | $-12M | $-25M | $23M | · | $12M | |
| Market Cap | · | $637M | · | $678M | $668M | $677M | · | $1.08B | $1.02B | $1.49B | · | $273M | $199M | $119M | · | $236M | |
| P/E | -30.0 | -63.4 | · | · | -367.5 | 386.0 | · | -8.6 | -8.4 | -12.4 | · | -8.1 | -4.8 | 6.1 | · | 19.7 | |
| P/S | · | 5.3 | · | 6.2 | 6.3 | 6.7 | · | 10.2 | 9.1 | 12.9 | · | · | · | · | · | · | |
| P/B | · | 6.3 | · | 6.7 | 7.3 | 9.9 | · | 17.0 | 16.9 | 26.4 | · | 77.7 | -7.0 | -4.6 | · | 8.0 | |
| P / Tangible Book | 6.8 | 6.6 | · | 7.0 | 7.7 | 10.7 | · | 17.1 | 17.0 | 26.5 | · | 77.7 | · | · | · | 8.0 | |
| P / Cash Flow | · | 200.2 | · | · | · | -5244.6 | · | · | · | 517.8 | · | · | · | -19.1 | · | · | |
| Earnings Yield | -3.3% | -1.6% | · | 0.00% | -0.27% | 0.26% | · | -11.6% | -11.9% | -8.1% | · | -12.4% | -20.9% | 16.5% | · | 5.1% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | · | · | 2986.2% | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $117M | $106M | $113M | $102M | $7M |
| Brüt Kâr Marjı % | · | 96.3% | 95.9% | · | · |
| Faaliyet Kâr Marjı % | 9.8% | 15.3% | -59.3% | · | · |
| Net Gelir | $10M | $18M | $-85M | $4M | $-88M |
| Seyreltilmiş Hisse Başı Kâr | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 5.6 | 3.3 | 2.9 | 1.7 | · |
| Cari Oran | 4.6 | 2.4 | 1.7 | 1.3 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-180.0K | $-6M | $17M | · | · |
Kurumsal Sahipler (13F) 61 dosya · $65.5M toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
61
Tutulan Değer
$65.5M
Yeni pozisyonlar
11
Çıkan pozisyonlar
7
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 11 (-4 önceki Ç'ye göre) | 7 (+4 önceki Ç'ye göre) | 31 (+13 önceki Ç'ye göre) | 9 (-2 önceki Ç'ye göre) | +5.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| HSG Holding Ltd | $24.714.470 | 3.750.299 | 37,75% | Hisse senetleri |
| VANGUARD GROUP INC | $8.483.219 | 1.201.589 | 12,96% | Hisse senetleri |
| BlackRock, Inc. | $6.550.085 | 993.943 | 10,01% | Hisse senetleri |
| Octagon Capital Advisors LP | $6.289.601 | 954.416 | 9,61% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.778.949 | 876.927 | 8,83% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $3.513.176 | 532.950 | 5,37% | Hisse senetleri |
| STATE STREET CORP | $1.617.199 | 245.402 | 2,47% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.214.445 | 184.286 | 1,86% | Hisse senetleri |
| NORTHERN TRUST CORP | $1.117.249 | 169.537 | 1,71% | Hisse senetleri |
| SBI Securities Co., Ltd. | $1.098.883 | 166.750 | 1,68% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $995.571 | 151.073 | 1,52% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $816.850 | 123.953 | 1,25% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $568.289 | 86.235 | 0,87% | Hisse senetleri |
| Bank of New York Mellon Corp | $413.523 | 62.750 | 0,63% | Hisse senetleri |
| MORGAN STANLEY | $274.743 | 41.691 | 0,42% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $171.392 | 24.590 | 0,26% | Hisse senetleri |
| STRS OHIO | $170.022 | 25.800 | 0,26% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $166.516 | 25.268 | 0,25% | Hisse senetleri |
| Nuveen, LLC | $161.488 | 24.505 | 0,25% | Hisse senetleri |
| UBS Group AG | $123.649 | 18.763 | 0,19% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $121.836 | 18.488 | 0,19% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $118.218 | 17.939 | 0,18% | Hisse senetleri |
| RHUMBLINE ADVISERS | $111.131 | 16.865 | 0,17% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $107.397 | 16.297 | 0,16% | Hisse senetleri |
| FMR LLC | $98.679 | 14.974 | 0,15% | Hisse senetleri |
| ROYAL BANK OF CANADA | $87.000 | 13.195 | 0,13% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $82.539 | 12.525 | 0,13% | Hisse senetleri |
| Polymer Capital Management (US) LLC | $77.630 | 11.780 | 0,12% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $65.788 | 9.983 | 0,10% | Hisse senetleri |
| Police & Firemen's Retirement System of New Jersey | $59.382 | 9.011 | 0,09% | Hisse senetleri |
| CITIGROUP INC | $56.582 | 8.586 | 0,09% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55.659 | 8.446 | 0,09% | Hisse senetleri |
| JPMORGAN CHASE & CO | $50.510 | 7.831 | 0,08% | Hisse senetleri |
| Russell Investments Group, Ltd. | $24.930 | 3.783 | 0,04% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $22.973 | 3.486 | 0,04% | Hisse senetleri |
| BARCLAYS PLC | $21.273 | 3.228 | 0,03% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $17.793 | 2.700 | 0,03% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $16.271 | 2.469 | 0,02% | Hisse senetleri |
| Legal & General Group Plc | $13.536 | 2.054 | 0,02% | Hisse senetleri |
| Ameritas Investment Partners, Inc. | $4.501 | 683 | 0,01% | Hisse senetleri |
| Activest Wealth Management | $3.512 | 533 | 0,01% | Hisse senetleri |
| Arax Advisory Partners | $1.621 | 246 | 0,00% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.094 | 166 | 0,00% | Hisse senetleri |
| Sterling Capital Management LLC | $1.061 | 161 | 0,00% | Hisse senetleri |
| GAMMA Investing LLC | $962 | 146 | 0,00% | Hisse senetleri |
| CWM, LLC | $725 | 104 | 0,00% | Hisse senetleri |
| Physician Wealth Advisors, Inc. | $541 | 82 | 0,00% | Hisse senetleri |
| Bare Financial Services, Inc | $521 | 79 | 0,00% | Hisse senetleri |
| GoalVest Advisory LLC | $367 | 50 | 0,00% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $288 | 44 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 21 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Songjiang Ma, Yueying Zhu | 07 Mayıs 2026 | 6,33% | Değişiklik | M&A / satış | SEC |
| Ying Luo, Ping Lan | 06 Mayıs 2026 | 8,60% | Değişiklik | M&A / satış | SEC |
| GNI USA, Inc., GNI Group Ltd. ×4 başvurular | 06 Mayıs 2026 | 69,10% | Değişiklik | M&A / satış | SEC |
| Ying Luo (“Mr. Luo”), Ping Lan | 06 Eylül 2024 | · | İlk başvuru | Pasif yatırım | SEC |
| Songjiang Ma (“Mr. Ma”), Yueying Zhu | 06 Eylül 2024 | · | İlk başvuru | Pasif yatırım | SEC |
| GNI Group Ltd., GNI Hong Kong Limited, GNI USA, Inc. ×2 başvurular | 31 Ekim 2023 | · | İlk başvuru | · | SEC |
| JDS1, LLC, CCUR Holdings, Inc., CIDM II, LLC, Julian D. Singer, David S. Oros ×13 başvurular | 07 Ekim 2022 | · | İlk başvuru | Pasif yatırım | SEC |
| JEC II Associates, LLC, The Heidi S. Shippell-Heiland 2008 Irrevocable Trust, Michael Torok ×4 başvurular | 22 Eylül 2022 | · | İlk başvuru | · | SEC |
| Julian Singer, JDS1, LLC 2, CCUR Holdings, Inc., David S. Oros ×3 başvurular | 27 Ocak 2022 | · | İlk başvuru | · | SEC |
| 22NW Fund, LP, 22 NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., Aron R. English ×2 başvurular | 05 Ağustos 2020 | · | İlk başvuru | · | SEC |
| CCUR Holdings, Inc., Wayne Barr, Jr., JDS1, LLC, David S. Oros, Julian Singer ×3 başvurular | 17 Ocak 2020 | · | İlk başvuru | · | SEC |
| Morgenthaler Management Partners VIII, LLC (“MMP VIII”), Morgenthaler Partners VIII, L.P. (“MP VIII”), Robert C. Bellas, Jr. (“Bellas”), Ralph E. Christoffersen (“Christoffersen”), John Lutsi (“Lutsi”), Gary J. Morgenthaler (“Morgenthaler”), Robert D. Pavey (“Pavey”), Gary R. Little (“Little”) | 14 Şubat 2018 | · | İlk başvuru | · | SEC |
| HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, James H. Cavanaugh, Ph.D., Harold R. Werner, John W. Littlechild, Christopher Mirabelli, Ph.D., Augustine Lawlor ×2 başvurular | 09 Şubat 2018 | · | İlk başvuru | · | SEC |
| 23 Mayıs 2017 | · | İlk başvuru | · | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, Michael James Barrett, Peter J. Barris, Scott D. Sandell ×4 başvurular | 29 Mart 2017 | · | İlk başvuru | · | SEC |
| Essex Woodlands Health Ventures VIII, LLC, Essex Woodlands Health Ventures VIII, L.P., Essex Woodlands Health Ventures Fund VIII, L.P., Jeff Himawan, Ph.D., James Currie, Martin Sutter, Immanuel Thangaraj, Petri Vainio, Ron Eastman, Steve Wiggins, Guido Neels | 31 Ağustos 2015 | · | İlk başvuru | Pasif yatırım | SEC |
| Morgenthaler Management Partners VIII, LLC, Morgenthaler Partners VIII, L.P., Ralph Christoffersen, Robert Bellas, John Lutsi, Gary Morgenthaler, Robert Pavey, Gary Little | 31 Ağustos 2015 | · | İlk başvuru | Pasif yatırım | SEC |
| Rosetta Capital V LP, Rosetta Capital V GP LP, Rosetta Capital V GP Limited, Rosetta Capital Limited | 28 Ağustos 2015 | · | İlk başvuru | Pasif yatırım | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BIOTECHNOLOGY VALUE FUND II, L.P., BVF INVESTMENTS, L.L.C., INVESTMENT 10, L.L.C., MSI BVF SPV, LLC, BVF PARTNERS, L.P., BFV INC., MARK N. LAMPERT ×6 başvurular | 21 Ağustos 2015 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 29 Ocak 2008 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 28 Ocak 2008 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 66 içeriden öğrenenler · 26 yöneticiler · 32 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Ying Luo | Chief Executive Officer | 08 Haziran 2026 A | 2.565.226 | 0 | 2 | $-82.927 |
| Han Ying | Chief Executive Officer | 14 Ağustos 2024 A | · | 0 | 0 | $0 |
| Charles C Wu | Chief Executive Officer | 20 Kasım 2023 A | · | 0 | 0 | $0 |
| Donald J Debethizy | President and CEO | 04 Mayıs 2012 A | 798 | 0 | 0 | $0 |
| Thomas Wilson Eastling | Chief Financial Officer | 04 Mayıs 2026 A | 15.000 | 0 | 0 | $0 |
| Ruoyu Chen | Chief Financial Officer | 07 Ocak 2026 A | · | 0 | 0 | $0 |
| Seline E. Miller | SVP Finance; Interim CFO & PAO | 31 Ağustos 2023 D | 0 | 0 | 0 | $0 |
| Clinton Musil | Chief Financial Officer | 08 Şubat 2021 A | · | 0 | 0 | $0 |
| Fletcher Payne | Chief Financial Officer | 12 Ağustos 2019 A | 3.744 | 0 | 0 | $0 |
| Mauri K Hodges | Treasurer, CFO | 14 Ağustos 2015 A | 1.159 | 0 | 0 | $0 |
| Alan A Musso | SVP, Fin+Admin, CFO & Treas | 17 Ekim 2014 A | 57.799 | 0 | 0 | $0 |
| Songjiang Ma | President | 28 Mayıs 2025 S | 2.806.084 | 0 | 0 | $0 |
| Weiguo Ye | Chief Operating Officer | 18 Haziran 2026 M | 700.000 | 0 | 16 | $-869.947 |
| Joshua Benjamin Bergmann | GC and Corporate Secretary | 08 Haziran 2026 A | · | 0 | 0 | $0 |
| Grant E. Blouse | Chief Scientific Officer | 09 Ağustos 2022 P | 9.417 | 0 | 0 | $0 |
| Howard Levy | Chief Medical Officer | 09 Ağustos 2021 P | 639 | 0 | 0 | $0 |
| Veronica Cai | Controller | 13 Mart 2020 P | 7.353 | 0 | 0 | $0 |
| Edwin Madison | Chief Scientific Officer | 22 Ekim 2015 A | 31.008 | 0 | 0 | $0 |
| Patrick C. Rock | Secretary, GC | 14 Ağustos 2015 A | 45.000 | 0 | 0 | $0 |
| Steven M. Toler | VP, Clin Pharm Sciences | 17 Ekim 2014 A | 46.000 | 0 | 0 | $0 |
| David A. Hosford | VP, Clin Dev & Reg Affairs | 23 Ocak 2014 A | · | 0 | 0 | $0 |
| Karen A Hicks | VP, Human Resources | 17 Ocak 2013 A | 0 | 0 | 0 | $0 |
| Peter A Zorn | SVP, Lgl Affrs, GC & Secretary | 17 Ocak 2013 A | 0 | 0 | 0 | $0 |
| Merouane Bencherif | SVP and Senior Scien Fellow | 17 Ocak 2013 A | 15.938 | 0 | 0 | $0 |
| William S Caldwell | SVP - Drug Discovery and Dev. | 20 Eylül 2011 G | 500 | 0 | 0 | $0 |
| Geoffrey C Dunbar | SVP, Clin. Dev. & Reg. Affairs | 29 Mart 2011 A | 1.153 | 0 | 0 | $0 |
| Claire Weston | Yönetim kurulu üyesi | 03 Ağustos 2026 A | · | 0 | 0 | $0 |
| Maxwell Kirkby | Yönetim kurulu üyesi | 03 Ağustos 2026 A | · | 0 | 0 | $0 |
| Dan Weng | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Ping Zhang | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Rodney L Nussbaum | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Renate Parry | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Gordon Carmichael | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| David M. Epstein | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Nassim Usman | Yönetim kurulu üyesi | 28 Haziran 2024 M | 1.636 | 0 | 0 | $0 |
| Andrea Hunt | Yönetim kurulu üyesi | 31 Ağustos 2023 D | 0 | 0 | 0 | $0 |
| Augustine Lawlor | Yönetim kurulu üyesi | 31 Ağustos 2023 D | 0 | 0 | 0 | $0 |
| Geoffrey Ling M.D. | Yönetim kurulu üyesi | 07 Ocak 2022 A | 31.790 | 0 | 0 | $0 |
| Eddie Williams | Yönetim kurulu üyesi | 07 Ocak 2022 A | 34.804 | 0 | 0 | $0 |
| Errol B Desouza | Yönetim kurulu üyesi | 01 Ekim 2021 A | 29.801 | 0 | 0 | $0 |
| Jeanne Y Jew | Yönetim kurulu üyesi | 09 Eylül 2021 A | · | 0 | 0 | $0 |
| Sharon Tetlow | Yönetim kurulu üyesi | 09 Haziran 2021 A | 3.635 | 0 | 0 | $0 |
| John P Richard | Yönetim kurulu üyesi | 13 Mart 2020 P | 3.716 | 0 | 0 | $0 |
| Stephen A Hill | Yönetim kurulu üyesi | 06 Eylül 2018 D | 1.190 | 0 | 0 | $0 |
| Harold E Selick | Yönetim kurulu üyesi | 16 Ocak 2018 A | 16.614 | 0 | 0 | $0 |
| Jeff Himawan | Yönetim kurulu üyesi | 20 Ağustos 2015 J | 1.179.352 | 0 | 0 | $0 |
| Alan W Dunton | Yönetim kurulu üyesi | 14 Ağustos 2015 A | 10.000 | 0 | 0 | $0 |
| Charles A Blixt | Yönetim kurulu üyesi | 14 Ağustos 2015 A | 10.000 | 0 | 0 | $0 |
| Julia R Brown | Yönetim kurulu üyesi | 14 Ağustos 2015 A | 10.000 | 0 | 0 | $0 |
| SKALETSKY MARK B | Yönetim kurulu üyesi | 07 Haziran 2013 A | 11.332 | 0 | 0 | $0 |
| Steven Burrill | Yönetim kurulu üyesi | 31 Temmuz 2012 M | 4.333 | 0 | 0 | $0 |
| Ralph Snyderman | Yönetim kurulu üyesi | 07 Haziran 2012 A | 0 | 0 | 0 | $0 |
| Ann Hanham | Yönetim kurulu üyesi | 18 Nisan 2006 C | 778.062 | 0 | 0 | $0 |
| GNI Hong Kong Ltd | 10% sahip | 27 Ekim 2023 J | 0 | 0 | 0 | $0 |
| Scott D. Sandell | 10% sahip | 05 Aralık 2013 S | 0 | 0 | 0 | $0 |
| Peter J Barris | 10% sahip | 05 Aralık 2013 S | 0 | 0 | 0 | $0 |
| James M Barrett | 10% sahip | 03 Aralık 2013 M | 0 | 0 | 0 | $0 |
| Richard C Kramlich | 10% sahip | 19 Kasım 2012 X | 5.333 | 0 | 0 | $0 |
| NEA Partners 10, Limited Partnership | 10% sahip | 17 Ocak 2008 J | 4.563.512 | 0 | 0 | $0 |
| Iii Eugene A Trainor | 10% sahip | 17 Ocak 2008 J | 4.563.512 | 0 | 0 | $0 |
| New Enterprise Associates 10, Limited Partnership | 10% sahip | 17 Ocak 2008 J | 4.563.512 | 0 | 0 | $0 |
| Mark W Perry | 10% sahip | 17 Ocak 2008 J | 4.563.512 | 0 | 0 | $0 |
| Charles W Newhall III | 10% sahip | 17 Ocak 2008 J | 4.563.512 | 0 | 0 | $0 |
| Peter Morris | 10% sahip | 06 Şubat 2007 M | 2.000 | 0 | 0 | $0 |
| Jeffrey P Brennan | · | 17 Ocak 2013 A | 0 | 0 | 0 | $0 |
| Elaine V Jones | · | 29 Kasım 2007 X | 27.500 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 11 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IWO · iShares Trust | 0,01% | 120.729 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,00% | 8.775 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 387.159 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 238.693 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 614.654 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 104.607 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.047 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13.494 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 805 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,00% | 320 NS | 31 Temmuz 2026 | N-PORT |
| IWN · iShares Trust | · | 41.397 SH | 11 Eylül 2026 | Günlük |
GYRE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 9 analist
AL
Medyan hedef
$18.00
+153,2%
3 33,3%
Güçlü Al
5 55,6%
Al
1 11,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-10-02Ortalama hedef $18.67 +162,5%
← Tüm hedeflerin altında
Mevcut fiyat $7.11
Düşük$18.00
Ortalama$18.67
Yüksek$20.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| ACHV | · | -4.0 | · | · | · | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| FTH | · | · | · | · | · | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 7, 2026